Coya Therapeutics Inc.

NASDAQ: COYA · Real-Time Price · USD
6.09
0.41 (7.12%)
At close: Aug 15, 2025, 3:59 PM
6.05
-0.66%
After-hours: Aug 15, 2025, 04:50 PM EDT

Coya Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
3.55M 6M n/a n/a
Cost of Revenue
n/a n/a 27.36K 16.13K
Gross Profit
3.55M 6M -27.36K -16.13K
Operating Income
-17.25M -7.9M -9.81M -4.87M
Interest Income
n/a n/a n/a n/a
Pretax Income
-15.6M -7.26M -12.24M -4.89M
Net Income
-14.88M -7.99M -12.24M -4.89M
Selling & General & Admin
8.89M 7.83M 4.85M 2.31M
Research & Development
11.89M 6.04M 4.41M 2.54M
Other Expenses
27K 28K 28K 16K
Operating Expenses
20.8M 13.91M 9.29M 4.87M
Interest Expense
n/a n/a 2.43M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
20.8M 13.91M 9.29M 4.87M
Income Tax Expense
-720K 723.85K n/a -21.48K
Shares Outstanding (Basic)
15.24M 10.16M 2.59M 9.68M
Shares Outstanding (Diluted)
15.24M 10.16M 2.59M 6.6M
EPS (Basic)
-0.98 -0.79 -4.73 -0.51
EPS (Diluted)
-0.98 -0.79 -4.73 -0.74
EBITDA
-17.22M -7.88M -12.22M -4.85M
EBIT
-17.23M -7.9M -12.24M -4.87M
Depreciation & Amortization
27.36K 27.36K 27.36K 16.13K